tiprankstipranks
Advertisement
Advertisement

AU:OSL Stock Latest News

OncoSil Highlights Financial Position and Niche Cancer Device Focus
Company AnnouncementsOncoSil Highlights Financial Position and Niche Cancer Device Focus
7d ago
OSL
OncoSil to Showcase Real-World Pancreatic Cancer Data at Major Nuclear Medicine Congress
PremiumCompany Announcements
OncoSil to Showcase Real-World Pancreatic Cancer Data at Major Nuclear Medicine Congress
8d ago
OSL
OncoSil validates scalable Australian manufacturing for pancreatic cancer device
PremiumCompany Announcements
OncoSil validates scalable Australian manufacturing for pancreatic cancer device
9d ago
OSL
OncoSil trial data at ESMO GI 2026 bolster case for FOLFIRINOX label expansion
PremiumCompany Announcements
OncoSil trial data at ESMO GI 2026 bolster case for FOLFIRINOX label expansion
16d ago
OSL
OncoSil Seeks First U.S. Approval With FDA Filing for Cancer Device
PremiumCompany Announcements
OncoSil Seeks First U.S. Approval With FDA Filing for Cancer Device
19d ago
OSL
OncoSil Joins EU PALACROS Consortium With Cost-Efficient Pancreatic Cancer Trial
PremiumCompany AnnouncementsOncoSil Joins EU PALACROS Consortium With Cost-Efficient Pancreatic Cancer Trial
20d ago
OSL
OncoSil trial data wins ESMO GI spotlight with promising pancreatic cancer results
Premium
Company Announcements
OncoSil trial data wins ESMO GI spotlight with promising pancreatic cancer results
22d ago
OSL
OncoSil to Release 41,067 Escrowed Shares Issued as Director Fees
Premium
Company Announcements
OncoSil to Release 41,067 Escrowed Shares Issued as Director Fees
23d ago
OSL
OncoSil flags FDA progress and early TRIPP-FFX data in investor update
PremiumCompany Announcements
OncoSil flags FDA progress and early TRIPP-FFX data in investor update
1M ago
OSL
OncoSil Nears Final FDA HDE Decision for Rare Bile Duct Cancer Device
PremiumCompany Announcements
OncoSil Nears Final FDA HDE Decision for Rare Bile Duct Cancer Device
1M ago
OSL
OncoSil Seeks Trading Halt Ahead of Key Trial Results and FDA Update
PremiumCompany Announcements
OncoSil Seeks Trading Halt Ahead of Key Trial Results and FDA Update
2M ago
OSL
OncoSil on track for TRIPP-FFX data as it targets broader EU approval for pancreatic cancer device
PremiumCompany Announcements
OncoSil on track for TRIPP-FFX data as it targets broader EU approval for pancreatic cancer device
2M ago
OSL
OncoSil Seeks ASX Quotation for New Employee Incentive Shares
PremiumCompany AnnouncementsOncoSil Seeks ASX Quotation for New Employee Incentive Shares
2M ago
OSL
OncoSil Issues New Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
OncoSil Issues New Unquoted Options Under Employee Incentive Scheme
2M ago
OSL
OncoSil strengthens governance with new joint company secretary
Premium
Company Announcements
OncoSil strengthens governance with new joint company secretary
2M ago
OSL
OncoSil gains ASCO spotlight as Spanish data bolster pancreatic cancer device
PremiumCompany Announcements
OncoSil gains ASCO spotlight as Spanish data bolster pancreatic cancer device
2M ago
OSL
OncoSil Updates Market on Change in Substantial Shareholder Interests
PremiumCompany Announcements
OncoSil Updates Market on Change in Substantial Shareholder Interests
4M ago
OSL
OncoSil Director Increases Indirect Stake via Capital Raising
PremiumCompany Announcements
OncoSil Director Increases Indirect Stake via Capital Raising
4M ago
OSL
OncoSil Flags Isolated Administrative Lapse in Director Interest Disclosure
PremiumCompany Announcements
OncoSil Flags Isolated Administrative Lapse in Director Interest Disclosure
4M ago
OSL
OncoSil Medical Securities Reinstated to ASX Quotation
PremiumCompany AnnouncementsOncoSil Medical Securities Reinstated to ASX Quotation
4M ago
OSL
OncoSil Raises Institutional Capital via Share Placement and Issues Cleansing Notice
Premium
Company Announcements
OncoSil Raises Institutional Capital via Share Placement and Issues Cleansing Notice
4M ago
OSL
OncoSil Options Register Shows High Concentration Among Institutional Holders
Premium
Company Announcements
OncoSil Options Register Shows High Concentration Among Institutional Holders
4M ago
OSL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >